ACE2 and COVID-19: The involvement of ACE2 in the mediation of the SARS-CoV-2 penetration of host cells was considered; as a result, it was also assumed that reducing ACE2 activity reduced bradykinin degradation with significant cough and shortness of breath, a key functionality in the pathogenesis of COVID-19.